Cancer Genetics Inc (NASDAQ:CGIX)

0.9401
Delayed Data
As of Apr 25
 -0.0699 / -6.92%
Today’s Change
0.90
Today|||52-Week Range
4.78
-49.18%
Year-to-Date
No recent news for Cancer Genetics Inc.

Today’s Trading

Previous close1.01
Today’s open1.00
Day’s range0.93 - 1.00
Volume686,296
Average volume (3 months)577,762
Market cap$51.3M
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+48.98%
Earnings growth (this year)+21.00%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+49.94%
P/E ratioNM
Price/Sales0.79
Price/Book1.37

Competitors

 Today’s
change
Today’s
% change
VRMLVermillion Inc-0.07-5.47%
GALTGalectin Therapeutic...+0.25+7.91%
TRILTrillium Therapeutic...-0.25-3.76%
IDXGInterpace Diagnostic...+0.01+0.63%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 16, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$27.0M
Annual profit (last year)-$15.8M
Net profit margin-58.42%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
EVP-Finance, Chief Executive &
Operating Officer
John A. Roberts
Medical Director &
VP-Hematopathology
Rita Shaknovich
Corporate headquarters
Rutherford, New Jersey

Forecasts